sowas wie Neid kenn ich nicht,ich mach auch keinen Wettbewerb,sondern versuche sachlich die etwaigen Schwachpunkte aufzuzeigen,wenn hier einer zu pushen versucht,was ich dir noch nicht mal unterstelle
und zumindest sollteste vielleicht den split 3:1 wissen:
JUN 14, 2002 (EventX/Knobias.com via COMTEX) -- eResearch Technology, Inc. (Nasdaq NM: ERES) will effect a 3-2 split of the issued and outstanding shares of common stock on July 17, 2002. The split becomes payable on July 16, 2002 to holders on record, June 25, 2002, according to Nasdaq Trader
As of April 30, 2002, the company reported that 6,962,130 shares of common stock were issued and outstanding. Following the split, the company will have approximately 10,443,195 shares outstanding.
Deswegen und wegen des guten Reports steigt sie!
eResearch Technology, Inc. (Nasdaq: ERES) provides integrated software applications and technology consulting services to the biotechnology, pharmaceutical and medical-device industries. Their products, designed to streamline clinical trials, use the Internet and other means of electronic data transfer to improve the accuracy, timeliness and efficiency of the various stages of the trials.Revenues for the most recent first quarter were $8.4 million, an increase of 42% over revenues of $5.9 million for the quarter ended March 31, 2001. EPS in the latest quarter grew to $0.10 vs. a loss in the year-ago first quarter.
dürfte aber wohl jetzt mal konsolidieren,zumindest Stochastik deutet darauf hin

chart.bigcharts.com/bc3/intchart/frames/...nd=7416&mocktick=1" style="max-width:560px" >